Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, open-label, single-dose, 3-period crossover, pharmacokinetic study designed to compare the systemic des-ciclesonide exposure of OMNARIS (ciclesonide) nasal spray, ciclesonide HFA [hydrofluoroalkane] nasal aerosol, and orally inhaled ciclesonide.

Next Previous
X
Search
Trial Profile

A randomized, open-label, single-dose, 3-period crossover, pharmacokinetic study designed to compare the systemic des-ciclesonide exposure of OMNARIS (ciclesonide) nasal spray, ciclesonide HFA [hydrofluoroalkane] nasal aerosol, and orally inhaled ciclesonide.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciclesonide (Primary) ; Ciclesonide (Primary)
  • Indications Allergic rhinitis
  • Focus Pharmacokinetics
  • Sponsors Covis Pharma

    • Most Recent Events

    • 08 Feb 2022 Trial focus changed from TU to PK, as the primary endpoint was amended
    • 07 Jun 2011 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 18 Mar 2008 Results presented at AAAAI in 2008

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top